Therefore, it is highly desirable to the pharmaceutical company, the various nomenclature committees, and the medical community in general that a global name be established for each new single-entity compound introduced.
Zato je poželjno za farmaceutsku kompaniju, razne nomenklaturne odbore, kao i medicinsku zajednicu u celini, da globalno ime bude uspostavljeno za svaki novo uvedeni entitet.